 Rohit Vashisht, PhD
 Biography | Stanford University, Palo Alto, California | Data Scientist | 2019 | Biomedical Informatics; Immunity, Transplantation and Infection | | Stanford University, Palo Alto, California | Post-Doctoral Fellow | 2018 | Biomedical Informatics | | Academy of Scientific and Innovative Research, New Delhi, India | PhD | 2015 | Data-Intensive Systems Level Analysis of Mycobacterium tuberculosis Genome for Drug Discovery | | Indian Institute of Science, Bangalore, India | Research Fellow | 2010 | Systems Biology of Mycobacterium Tuberculosis | | Acharya Institute of Technology, Bangalore, India | Bachelor of Engineering in Biotechnology | 2007 | Biotechnology |
Overview Rohit Vashisht, PhD
Rohit Vashisht is a clinical data scientist in Butte Lab at Bakar Computational Health Sciences Institute. Dr. Rohit's research involves statistical and machine learning analysis of large-scale real-world data in healthcare to generate real-world evidence for medical and policy level decision making. Dr. Rohit completed his post-doctoral tenure at Stanford University. He holds a Ph.D. in biomedical science from the Academy of Scientific and Innovative Research, New Delhi, India, and Bachelor of Engineering in biotechnology from Acharya Institute of Technology, Bangalore, India.
ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Treatment Patterns for Chronic Comorbid Conditions in Patients With Cancer Using a Large-Scale Observational Data Network. JCO Clin Cancer Inform. 2020 03; 4:171-183.
Chen R, Ryan P, Natarajan K, Falconer T, Crew KD, Reich CG, Vashisht R, Randhawa G, Shah NH, Hripcsak G. PMID: 32134687.
View in: PubMed Mentions: Fields: Translation: Humans
-
Development and validation of a prognostic model predicting symptomatic hemorrhagic transformation in acute ischemic stroke at scale in the OHDSI network. PLoS One. 2020; 15(1):e0226718.
Wang Q, Reps JM, Kostka KF, Ryan PB, Zou Y, Voss EA, Rijnbeek PR, Chen R, Rao GA, Morgan Stewart H, Williams AE, Williams RD, Van Zandt M, Falconer T, Fernandez-Chas M, Vashisht R, Pfohl SR, Shah NH, Kasthurirathne SN, You SC, Jiang Q, Reich C, Zhou Y. PMID: 31910437.
View in: PubMed Mentions: Fields: Translation: Humans
-
Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures. PLoS Med. 2019 04; 16(4):e1002786.
Warsinske H, Vashisht R, Khatri P. PMID: 31013272.
View in: PubMed Mentions: 10 Fields: Translation: HumansCells
-
Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative. JAMA Netw Open. 2018 08 03; 1(4):e181755.
Vashisht R, Jung K, Schuler A, Banda JM, Park RW, Jin S, Li L, Dudley JT, Johnson KW, Shervey MM, Xu H, Wu Y, Natrajan K, Hripcsak G, Jin P, Van Zandt M, Reckard A, Reich CG, Weaver J, Schuemie MJ, Ryan PB, Callahan A, Shah NH. PMID: 30646124.
View in: PubMed Mentions: 5 Fields: Translation: Humans
-
Impact of integrated psycho-socio-economic support on treatment outcome in drug resistant tuberculosis - A retrospective cohort study. Indian J Tuberc. 2019 Jan; 66(1):105-110.
Bhatt R, Chopra K, Vashisht R. PMID: 30797265.
View in: PubMed Mentions: 2 Fields: Translation: Humans
-
Learning Effective Treatment Pathways for Type-2 Diabetes from a clinical data warehouse. AMIA Annu Symp Proc. 2016; 2016:2036-2042.
Vashisht R, Jung K, Shah N. PMID: 28269963.
View in: PubMed Mentions: 3 Fields: Translation: Humans
-
Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis. J Transl Med. 2015 Mar 07; 13:83.
Vashisht R, Brahmachari SK. PMID: 25880846.
View in: PubMed Mentions: 11 Fields: Translation: Humans
-
Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets. J Transl Med. 2014 Oct 11; 12:263.
Vashisht R, Bhat AG, Kushwaha S, Bhardwaj A, Brahmachari SK. PMID: 25304862.
View in: PubMed Mentions: 9 Fields: Translation: Cells
-
Social networks to biological networks: systems biology of Mycobacterium tuberculosis. Mol Biosyst. 2013 Jul; 9(7):1584-93.
Vashisht R, Bhardwaj A, Brahmachari SK. PMID: 23629487.
View in: PubMed Mentions: 4 Fields: Translation: HumansCells
-
Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis. PLoS One. 2012; 7(7):e39808.
Vashisht R, Mondal AK, Jain A, Shah A, Vishnoi P, Priyadarshini P, Bhattacharyya K, Rohira H, Bhat AG, Passi A, Mukherjee K, Choudhary KS, Kumar V, Arora A, Munusamy P, Subramanian A, Venkatachalam A, Gayathri S, Raj S, Chitra V, Verma K, Zaheer S, Balaganesh J, Gurusamy M, Razeeth M, Raja I, Thandapani M, Mevada V, Soni R, Rana S, Ramanna GM, Raghavan S, Subramanya SN, Kholia T, Patel R, Bhavnani V, Chiranjeevi L, Sengupta S, Singh PK, Atray N, Gandhi S, Avasthi TS, Nisthar S, Anurag M, Sharma P, Hasija Y, Dash D, Sharma A, Scaria V, Thomas Z, Chandra N, Brahmachari SK, Bhardwaj A. PMID: 22808064.
View in: PubMed Mentions: 12 Fields: Translation: HumansCells
-
Modeling metabolic adjustment in Mycobacterium tuberculosis upon treatment with isoniazid. Syst Synth Biol. 2010 Dec; 4(4):299-309.
Bhat AG, Vashisht R, Chandra N. PMID: 22132057.
View in: PubMed Mentions:
-
Protein-protein interaction networks suggest different targets have different propensities for triggering drug resistance. Syst Synth Biol. 2010 Dec; 4(4):311-22.
Padiadpu J, Vashisht R, Chandra N. PMID: 22132058.
View in: PubMed Mentions:
-
Strategies for efficient disruption of metabolism in Mycobacterium tuberculosis from network analysis. Mol Biosyst. 2009 Dec; 5(12):1740-51.
Raman K, Vashisht R, Chandra N. PMID: 19593474.
View in: PubMed Mentions: 12 Fields: Translation: Cells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2009 | 1 | | 2011 | 2 | | 2012 | 1 | | 2013 | 1 | | 2014 | 1 | | 2015 | 1 | | 2017 | 1 | | 2018 | 2 | | 2019 | 1 | | 2020 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|